Skin pigmentation disease

Skin pigmentation disease Submit Abstract Register Now

Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites.

  • monobenzyl ether of hydroquinone agent in vitiligo
  • strict sun protection
  • psychological and cultural issues
  • common and uncommon side effects
  • combination therapy
  • Diphencyprone, Imiquimod potential treatment

Skin pigmentation disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in